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Background: The Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5), includes a new
‘With Mixed Features’ specifier for mood episodes. In (hypo-)manic episodes, the specifier is given if three or more
depressive symptoms are present nearly every day during the episode. A new module of the Mini International
Neuropsychiatric Interview (M.I.N.I.) has been developed as a patient-completed questionnaire to evaluate the
DSM-5 specifier for (hypo-)manic episodes. The objective of this study was to validate this new module.
Methods: In Phase I, patients with a manic episode in the past 6 months completed the module and were asked
whether the wording was clear, understandable, relevant and specific. Based on their feedback, the module was
refined and finalised. In Phase II, psychiatrists each invited five patients to complete the module. The psychiatrists
completed record forms for these five patients, which included their diagnoses, made according to DSM-5 criteria
during clinical interviewing. The module was validated by comparing depressive symptoms reported by the patients
themselves using the M.I.N.I. module with those evaluated by their psychiatrist using DSM-5 criteria during clinical interviewing.
Results and discussion: In Phase I, a few changes were made to the M.I.N.I. module based on feedback from
20 patients (60% of whom had mixed features). In Phase II, 23 psychiatrists completed record forms for 115 patients,
99 (86.1%) of whom completed the M.I.N.I. module. Agreement between psychiatrists' DSM-5 diagnoses and patients'
M.I.N.I. responses was substantial (Cohen's kappa coefficient, 0.60). The overall sensitivity of the M.I.N.I. was 0.91 and its
specificity was 0.70. Sensitivity ranged from 0.63 for psychomotor retardation to 0.90 for suicidal thoughts. Specificity
ranged from 0.63 for diminished interest/pleasure to 0.90 for suicidal thoughts. The module's positive and negative
predictive values were 0.72 and 0.90, respectively. In summary, the M.I.N.I. module demonstrated good concurrent
validity with psychiatrists' evaluation of DSM-5 mixed features in manic patients, accurately detecting mixed features
with limited risk of over-diagnosis. Due to its simplicity, the M.I.N.I. module could be incorporated into routine
psychiatric evaluation of patients with manic episodes. It could also provide a valuable standardised tool for clinical
and epidemiological research.
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Mood disorders are commonly divided into three major
categories: unipolar mood disorders (major depressive
disorder, dysthymic disorder), bipolar mood disorders
(bipolar I disorder, bipolar II disorder, cyclothymic
disorder) and mood disorders with a known aetiology
(substance-induced mood disorder, mood disorder due
to a general medical condition) (American Psychiatric
Association 2000). Depression and mania are often con-
sidered to be at opposite ends of the mood spectrum,
but they can coexist in what are termed ‘mixed states’.
Bipolar disorder is a chronic disease characterised by
periods of mania or hypomania (episodes of elevated
moods, extreme irritability, decreased sleep and increased
energy), depression (overwhelming feelings of sadness,
anhedonia, suicidal thoughts) or a combination of
both (mixed states). The prevalence of bipolar dis-
order is estimated to be approximately 1% to 2%
(Fagiolini et al. 2013).
In the American Psychiatric Association's Diagnostic and
Statistical Manual of Mental Disorders, fourth edition-text
revision (DSM-IV-TR), the diagnostic criteria for a ‘mixed
episode’ include a requirement that the patient meets the
criteria for both a manic episode and a major depressive
episode (except for duration) nearly every day during at
least a 1-week period (American Psychiatric Association
2000). When reviewing the latest research evidence for the
Diagnostic and Statistical Manual of Mental Disorders, fifth
edition (DSM-5), published in May 2013, it was recognised
that individuals rarely meet the full criteria for both a manic
episode and major depressive episode at the same time,
meaning that patients with mixed manic and depressive
symptoms may not necessarily be accurately diagnosed
and receive the most appropriate treatment (American
Psychiatric Association 2013a). Therefore, the DSM-IV-
TR criteria for a mixed episode have been removed and
replaced in DSM-5 with a new ‘With Mixed Features’ spe-
cifier for mood episodes, which can be applied to episodes
of hypomania, mania or major depression (American Psy-
chiatric Association 2013a). For hypomanic or manic epi-
sodes, the specifier is given if at least three of six defined
depressive symptoms are present nearly every day during
the most recent week of a manic episode or the most recent
4 days of a hypomanic episode. These depressive symptoms
are ‘prominent dysphoria or depressed mood’, ‘diminished
interest or pleasure in activities’, ‘psychomotor retardation’,
‘fatigue or loss of energy’, ‘feelings of worthlessness or
excessive/inappropriate guilt'’ and ‘recurrent thoughts
of death/suicide’ (American Psychiatric Association 2013a).
Since manic episodes with depressive symptoms are gener-
ally more severe and have a poorer prognosis than pure
manic episodes (González-Pinto et al. 2007, 2011; Goldberg
and McElroy 2007; Valentí et al. 2011), and because these
mixed states are common (affecting approximately one thirdof patients with bipolar disorder (González-Pinto et al. 2007,
2011)), it is hoped that this new specifier will enable cli-
nicians to diagnose patients suffering from concurrent
symptoms of mania/hypomania and depression more ac-
curately. This will allow clinicians to better tailor treatment
to their patients' particular needs (American Psychi-
atric Association 2013a). Furthermore, since mixed states
are not easily identified by clinicians, it is crucial to
systematically search for coexisting depression when a
patient has a manic episode in order to ensure a cor-
rect diagnosis.
Structured diagnostic interviews have become an integral
part of psychiatric medicine, not only being considered the
‘diagnostic gold standard’ in psychiatric research but also
increasingly being used to help ensure diagnostic precision
in clinical practice (Nordgaard et al. 2012). Whereas
information collected from open clinical interviews
may vary depending on how a particular question is
asked or framed, structured diagnostic interviews com-
prise questions that are precise and carefully linked to
diagnostic criteria, minimising the risk of ‘grey area’ and
associated variability. Structured diagnostic interviews
include the Mini International Neuropsychiatric Interview
(M.I.N.I.), which was developed as a simple tool to assist
clinicians to conduct psychiatric diagnoses according to
the DSM-IV and International Statistical Classification
of Diseases and Related Health Problems tenth revision
(ICD-10) criteria (Lecrubier et al. 1997; Sheehan et al. 1998).
The M.I.N.I has become a reference worldwide and
been translated into 65 languages. Recently, a new
module has been developed to evaluate the DSM-5
specifier ‘With Mixed Features’ for hypomanic and
manic episodes in a version that can be completed by
patients themselves, since self-assessment in acute
mania has been shown to be both feasible and valid
(Hantouche et al. 2001).
Presented here are the results of a study that was
conducted in order to validate the new M.I.N.I. module
in patients with manic episodes, by assessing the degree
of agreement between patients' M.I.N.I. module responses
and the diagnoses made by psychiatrists using DSM-5
criteria during clinical interviewing.Methods
This was a prospective, real-world study, involving psy-
chiatrists and patients with bipolar mania, which was
conducted in the UK in November 2012. The study was
divided into two phases. Phase I involved verification of
bipolar patients' acceptance and comprehension of the
questions comprising the M.I.N.I. module. Phase II involved
assessment of the degree of agreement between patients'
responses using the M.I.N.I. module versus DSM-5 cri-
teria as evaluated by psychiatrists.
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comprehension of the questions
Twenty patients with bipolar disorder who had experi-
enced a manic episode within the previous 6 months
completed the initial version of the M.I.N.I. module.
Patients were recruited using a quota system to achieve
an even mix of subjects currently experiencing two or
less or at least three depressive symptoms. The patients
were asked whether the wording of the introductory
sentence and each individual question of the M.I.N.I.
module was clear, understandable, relevant and specific.
Based on the patients' feedback, the wording was refined
on a question-by-question basis during a consensus
meeting of the study team, which was composed of the
authors and methodologists. This refinement was based
on a precise synthesis of the patients' answers (i.e. per-
centages of responses), together with their feelings about
the module. The adapted module was then finalised before
being used in Phase II.Phase II: assessment of the agreement between patients'
responses versus DSM-5 criteria as evaluated by
psychiatrists
Psychiatrist and patient selection
In order to be included in the study, physicians were
required to be psychiatrists, qualified for 3 to 30 years,
with a patient caseload comprising a minimum of 15
bipolar I patients per month. They were also required to
be actively managing and treating patients with bipolar I
disorder (i.e. to be the patients' ‘decision maker’), to agree
that bipolar I patients can experience depressive symp-
toms (of any severity) during a manic episode and to be
willing to invite patients to complete a patient question-
naire during a consultation (although patient participation
was voluntary). Psychiatrists were selected to ensure
regional spread across the UK and to include a mix of
hospital- and office-based psychiatrists.
For a patient to be included in the study, they were
required to be an adult (≥18 years old) and currently
diagnosed with bipolar I disorder, the diagnosis having
been made at least 1 year previously. They were also
required to have had a manic episode within approxi-
mately the past 3 months and to be currently receiving
treatment for this period of mania (but not necessarily
currently fulfilling full criteria for a manic episode).Study design
Each psychiatrist invited five patients to complete the
one-page M.I.N.I. module questionnaire (which had been
finalised during Phase I). These patients did not include
any who had participated in Phase I. The patient question-
naires were completed on paper on a voluntary basis and
returned via post.The psychiatrists then completed a 30-min online
survey, which comprised 5 min of profiling questions
followed by the completion of patient record forms for
the same five patients who had been invited to complete
the M.I.N.I. module. The profiling questions were used for
screening purposes and to capture information regarding
the psychiatrists’ caseload and setting, together with in-
formation about their practice, such as the percentage
of patients seen experiencing depressive symptoms dur-
ing manic episodes and the tools currently employed to
assess depressive symptoms. The patient record forms
captured information on each patient's demographic
characteristics, the onset of their most recent manic epi-
sode, treatments received for their manic episode and
the psychiatrist's diagnosis, made according to DSM-5
criteria during a clinical interview.M.I.N.I. module
The M.I.N.I. module consists of nine questions that
assess the presence/absence of depressive features
(six symptoms), as outlined in DSM-5 (Additional file 1).
The questions were based on the wording of the vali-
dated version of the M.I.N.I. (Lecrubier et al. 1997;
Sheehan et al. 1998) with slight changes after Phase I.
Compared with the original structured diagnostic
interview version of the M.I.N.I., this self-questionnaire
version was simplified using a points system for scoring.
For questions split into two parts (i.e. questions 2, 4
and 5), patients were counted as having that symptom
if ‘yes’ was selected for at least one part. If patients
answered ‘yes’ to both parts of the question, it was
counted as only one symptom to correspond with the
DSM-5 criteria count.Data analysis
The M.I.N.I. module was validated by comparing depres-
sive symptoms reported by the patients themselves using
the M.I.N.I. module with those reported by their psych-
iatrist assessing the presence of DSM-5 criteria during the
clinical interview. The six depressive symptoms assessed
were depressed mood, diminished interest/pleasure, psy-
chomotor retardation, fatigue/loss of energy, worthless/
guilty feelings and suicidal thoughts. The proportions
of patients experiencing two or less or at least three
depressive symptoms during a manic episode, as reported
by patients and psychiatrists using the M.I.N.I. module
and DSM-5 criteria, respectively, were compared. The
degree of agreement between the M.I.N.I. module
and DSM-5 criteria (as assessed by psychiatrists) was
calculated as the sum of ‘yes/yes’, ‘no/no’ and ‘don't
know/not answered’ responses, while the degree of
disagreement was calculated as the sum of all other
response combinations.
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inter-rater agreement and defined as follows:
κ ¼ Pr að Þ−Pr eð Þ
1−Pr eð Þ ;
where Pr(a) is the relative observed agreement between
the M.I.N.I. module and psychiatrist-rated DSM-5 cri-
teria and Pr(e) is the hypothetical probability of chance
agreement, using the observed data to calculate the
probabilities of each observer randomly saying each cat-
egory. If there is complete agreement, κ = 1; if there is
no agreement, other than what would be expected by
chance (as defined by Pr(e)), then κ = 0.
The sensitivity (i.e. ability to accurately identify the
presence of a symptom), specificity (i.e. ability to accur-
ately identify the absence of a symptom), positive pre-
dictive value (PPV) and negative predictive value (NPV)
were calculated for the M.I.N.I. module's ability to iden-
tify patients with at least three depressive symptoms
(i.e. to identify the presence of the DSM-5 ‘With
Mixed Features’ specifier), compared with psychiatrist-
rated DSM-5 criteria during clinical interviewing. Sen-
sitivity was calculated as the number of true positive
results divided by the number of true positive results
plus the number of false negative results. Specificity
was calculated as the number of true negative results
divided by the number of true negative results plus the
number of false positive results. PPV was calculated as the
number of true positive results divided by the number
of true positive results plus the number of false positive
results. NPV was calculated as the number of true nega-
tive results divided by the number of true negative re-
sults plus the number of false negative results. A true
positive result was recorded when the M.I.N.I. module
and the DSM-5 (as assessed by the psychiatrist) both
detected the presence of a symptom (‘yes/yes’). A true
negative result was recorded when the M.I.N.I. module
and the DSM-5 both detected the absence of a symptom
(‘no/no’). A false positive result was recorded when the
M.I.N.I. module detected the presence of a symptom
while the DSM-5 detected its absence (‘yes/no’). A false
negative result was recorded when the M.I.N.I. module
detected the absence of a symptom while the DSM-5
detected its presence (‘no/yes’).
κ, sensitivity, specificity, PPV and NPV were also cal-
culated for the M.I.N.I. module's ability to detect each of
the six individual depressive symptoms assessed.
Results
Phase I
Overall, 12 of 20 (60%) patients participating in Phase I
presented with mixed features (at least three depressive
symptoms). Feedback from all patients was analysed andthe wording of the M.I.N.I. module was revised and
finalised, as shown in Additional file 1. For example, in
the introductory sentence, ‘nearly every day’ was changed
to ‘almost every day’ at the suggestion of some patients,
since several understood ‘nearly every day’ to mean ‘most
days’. For questions where different symptoms were
assessed together (questions 2, 4 and 5), several patients
found it difficult to provide a ‘yes’ or ‘no’ response, so
these questions were split into two parts (‘a’ and ‘b’) in
the finalised version.
Phase II
Psychiatrist and patient characteristics
A total of 23 psychiatrists were included in the study
and altogether they completed patient record forms for
a total of 115 patients (i.e. five patients each). Of these
115 patients, 99 (86.1%) completed and returned the
M.I.N.I. module questionnaire. Details of the psychiatrists'
practice characteristics are shown in Table 1. Psychiatrists
were recruited from across the UK and had a mean dur-
ation of psychiatric experience of 17.8 years. Their mean
caseload was 139 patients/month, which included a mean
of 47 patients with bipolar I disorder per month, 52.3%
of whom were experiencing a manic episode at any one
time. Patient characteristics are summarised in Table 1.
The mean age of patients was 43.7 years and 53.9% were
female. All patients had recently experienced a manic
episode (as per inclusion criteria), and all consultations
took place during November 2012, in accordance with
the prospective design of the study.
Psychiatrist profiling
When psychiatrists were asked what proportion of their
patients with bipolar disorder exhibit depressive symp-
toms (regardless of severity) during a manic episode, 78%
reported values of 21% to 50%; the mean proportion
reported was 36%. When asked how they currently
assess depressive symptoms in patients with bipolar dis-
order, all the psychiatrists replied that they do so through
clinical examination and questioning of the patient, and
most (96%) replied that they also speak to the patient's
caregivers; 65% use diagnostic criteria (e.g. DSM-IV,
ICD-10), and 22% use a validated tool to measure depres-
sion. Psychiatrists reported that patients receive a variety
of treatments to manage their manic episodes; most com-
monly, antipsychotics (quetiapine, 34%; olanzapine, 25%)
and mood stabilisers (lithium, 23%; valproate semisodium,
19%; sodium valproate, 18%), with approximately 10%
of patients also prescribed antidepressants (Figure 1).
Validation of M.I.N.I. module against psychiatrist-rated
DSM-5 criteria
Psychiatrists diagnosed their patients during a clinical
interview using DSM-5 criteria and logged the results on
Table 1 Summary of psychiatrist practice details and
patient characteristics (Phase II)
Characteristics Value
(A) Psychiatrists n = 23
Years qualified, % (n)
5 to 9 4.3 (1)
10 to 14 39.1 (9)
15 to 19 8.7 (2)
≥20 47.8 (11)
Mean years qualified, n 17.8
Patient caseload
Mean total number of patients/month, n 139
Mean number of patients with bipolar I disorder/month, n 47
Patients experiencing a manic episode at any one time, % 52.3
Country regions, % (n)
London and South England 43.5 (10)
North England and Midlands 43.5 (10)
Scotland, Wales and Northern Ireland 13.0 (3)








Age range (years), % (n)
18 to 25 15.7 (18)
26 to 35 20.9 (24)
36 to 45 24.3 (28)
46 to 55 18.3 (21)
56 to 66 13.0 (15)
>66 7.8 (9)
Mean age, years 43.7
Onset of most recent/current manic episode, % (n)
Current month 18.3 (21)
1 month ago 33.0 (38)
2 months ago 28.7 (33)
3 months ago 17.4 (20)
4 months ago 2.6 (3)
Date of consultation, % (n)
1 to 18 November 2012 55.7 (64)
19 to 25 November 2012 20.9 (24)
26 to 30 November 2012 23.5 (27)
aMean percentage of psychiatrists spending time in each setting.
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that 74.8% (86/115) of patients experienced at least one
depressive symptom during a manic episode. The most
frequently observed depressive symptoms reported by
psychiatrists were depressed mood, diminished interest/
pleasure and fatigue; more severe symptoms (e.g. psycho-
motor retardation, recurrent thoughts of death/suicide)
were less frequently observed (Figure 2). Similarly, 81.8%
(81/99) of patients completing the M.I.N.I. module
reported experiencing at least one depressive symptom
during a manic episode. Consistent with the psychiatrists'
DSM-5 diagnoses, patients mainly reported experiencing
depressed mood, diminished interest/pleasure and fatigue;
more severe symptoms again were less frequently reported
(Figure 3). When matched records were compared, there
was a high level of agreement in symptom reporting be-
tween psychiatrists and patients across all symptoms;
the highest levels of agreement were for the most com-
mon symptom (depressed mood, 79%) and the most
severe symptom (suicidal thoughts, 85%), and the lowest
level of agreement was for the least severe symptom
(fatigue, 64% to 65%) (Figure 4).
Overall, there was 80% agreement between the M.I.N.I.
module and psychiatrist-rated DSM-5 criteria regarding
the number of depressive symptoms experienced by bi-
polar patients during a manic episode (Figure 5). According
to psychiatrists, 46.5% (46/99) of patients experienced at
least three depressive symptoms during a manic episode
and therefore met DSM-5 criteria for the ‘With Mixed
Features’ specifier. Patients were more likely than psychi-
atrists to report the presence of at least three depressive
symptoms, with 58.6% (58/99) of patients reporting
at least three depressive symptoms using the M.I.N.I.
module.
The overall sensitivity and specificity of the M.I.N.I.
module in identifying patients meeting the criteria for
the DSM-5 specifier were 0.91 and 0.70, respectively;
the overall PPV, NPV and κ were 0.72, 0.90 and 0.60, re-
spectively (Figure 5). The sensitivity of the M.I.N.I. mod-
ule in identifying individual depressive symptoms ranged
from 0.63 for psychomotor retardation to 0.90 for suicidal
thoughts, and its specificity ranged from 0.63 for di-
minished interest/pleasure to 0.90 for suicidal thoughts
(Table 2). PPVs ranged from 0.50 for psychomotor re-
tardation to 0.79 for depressed mood, NPVs ranged from
0.80 for fatigue/loss of energy to 0.97 for suicidal thoughts
and κ ranged from 0.42 for psychomotor retardation to
0.74 for suicidal thoughts (Table 2).
Discussion
This prospective, real-world study found that the M.I.N.I.
module demonstrates good concurrent validity with
psychiatrists' evaluation of DSM-5 mixed features in pa-
tients with bipolar mania. The M.I.N.I. module showed
Figure 1 Treatments received by patients to manage their manic episodes, as reported by psychiatrists (Phase II).
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limited risk of over-diagnosis. Although the psychia-
trists participating in the study estimated that approxi-
mately one third (36%) of bipolar I patients experience
depressive symptoms within a manic episode, this figureFigure 2 Depressive symptoms experienced by patients during a mandoubled when they were presented with the DSM-5 criteria
for mixed features, with 75% of patients experiencing
at least one depressive symptom. Indeed, according to
the psychiatrists, 46% of patients met the DSM-5 criteria
for the ‘With Mixed Features’ specifier. The agreementic episode, as evaluated by psychiatrists (Phase II).
Figure 3 Depressive symptoms experienced by patients during a manic episode, as reported by patients (Phase II).
Figure 4 Level of agreement/disagreement between depressive symptoms reported by psychiatrists (DSM-5) and patients (M.I.N.I. module).
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Figure 5 Validation of the M.I.N.I. module for assessment of the DSM-5 ‘With Mixed Features’ specifier. Number of patients experiencing
less than two or at least three depressive symptoms during a manic episode, as reported by patients using the M.I.N.I. module versus psychiatrists
using DSM-5 criteria during clinical interviewing. For questions that were split into two parts for patients (M.I.N.I. module questions 2, 4 and 5),
patients were counted as having that symptom if ‘yes’ was selected for at least one part. If patients answered ‘yes’ to both parts of the question,
it was counted as only one symptom to correspond with the DSM-5 criteria counta.
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assessment using the M.I.N.I. module to detect the presence
of the DSM-5 specifier was substantial, with a κ of 0.60.
The M.I.N.I. module's sensitivity and specificity were
also high (0.91 and 0.70, respectively), and there was
substantial agreement between psychiatrists and patients
with regard to the presence/absence of specific depressive
symptoms. Taken together, these findings demonstrate
that the M.I.N.I. module used as a self-questionnaire is
a robust assessment tool for identifying hypomanic and
manic bipolar patients meeting the criteria for the DSM-5
‘With Mixed Features’ specifier. This version could
be used as an optional module added to a clinicalTable 2 Validation of the M.I.N.I. module to identify
individual depressive symptoms (Phase II)
Symptom Sensitivity Specificity PPV NPV κ
Depressed mood 0.87 0.73 0.79 0.82 0.60
Diminished interest/pleasure 0.87 0.63 0.69 0.84 0.50
Psychomotor retardation 0.63 0.82 0.50 0.89 0.42
Fatigue/loss of energy 0.81 0.69 0.70 0.80 0.50
Worthless/guilty feelings 0.76 0.77 0.66 0.85 0.51
Suicidal thoughts 0.90 0.90 0.72 0.97 0.74
Proportions of patients experiencing each depressive symptom during a manic
episode, as reported by patients using the M.I.N.I. module compared with those
reported by psychiatrists using DSM-5 criteria during clinical interviewing. κ, Cohen’s
kappa coefficient; NPV, negative predictive value; PPV, positive predictive value.interview. Indeed, a ‘classical’ clinician module could
be developed and added to the M.I.N.I. in order to im-
prove the overall concordance with psychiatrists' diag-
nosis. It is important to highlight that the M.I.N.I.
module has been designed specifically to evaluate the
DSM-5 specifier for (hypo-)manic episodes in patients
with bipolar I or II disorders; therefore, a corresponding
module for evaluating ‘hypomanic features’ during bi-
polar or unipolar major depressive episodes should be
developed. It should also be pointed out that the M.I.N.I.
module is currently not applicable to paediatric bipolar
disorder.
A potential limitation of the M.I.N.I. module is that
the item corresponding to psychomotor retardation in
the DSM-5 ‘With Mixed Features’ specifier (Q3 of the
M.I.N.I. module) simply asks the patient ‘Since you have
been experiencing your current manic episode, have
you almost every day had times when you were slowed
down in your speech, thoughts, or movements?’, whereas
DSM-5 states that psychomotor retardation should be
‘observable by others; not merely subjective feelings of
being slowed down’ (American Psychiatric Association
2013b). Indeed, validation of the M.I.N.I. module showed
that Q3 had the lowest sensitivity and κ values of the six
items; however, it had one of the highest specificity
values (0.82), thereby limiting the likelihood of a false
positive result and, hence, over-diagnosis (Table 2). In
addition, psychomotor retardation was found to be the
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frequently, according to physicians using the DSM-5
‘With Mixed Features’ specifier during clinical interviewing
(Figure 2).
The replacement of the DSM-IV-TR diagnostic criteria
for a mixed episode with the new ‘With Mixed Features’
specifier in DSM-5 demonstrates a growing recognition
of the clinical relevance of subthreshold depression dur-
ing mania. Patients experiencing depressive symptoms
during a manic episode represent a more severe popula-
tion. Outcomes and prognosis in patients with depres-
sive symptoms during a manic episode are poorer than
those in patients with pure mania, with higher recurrence
rates, a higher prevalence of physical co-morbidity, a
higher risk of hospitalisation, more frequent co-morbid
substance abuse, and a greater risk of suicidal ideation
and suicide attempts (González-Pinto et al. 2007, 2011;
Goldberg and McElroy 2007; Valentí et al. 2011). More-
over, depressive symptoms during mania are highly
prevalent, occurring in approximately one third of pa-
tients with bipolar disorder (González-Pinto et al. 2007,
2011). Depending on the predominant symptoms, patients
with mixed features may demonstrate a poor response to
lithium and/or become less stable when taking antidepres-
sants (American Psychiatric Association 2013a), therefore
requiring treatment that is tailored to their particular needs.
The DSM-IV-TR criterion that patients must simultan-
eously meet all criteria for an episode of mania and an epi-
sode of major depression in order to be diagnosed with a
mixed episode have meant that the needs of many indivi-
duals in this severe patient subgroup have so far not been
adequately met. It is hoped that the DSM-5 ‘With Mixed
Features’ specifier will address this unmet need. Although
medications that are effective in treating mixed episodes as
defined by DSM-IV-TR criteria may also be effective in
treating mixed features according to criteria for the DSM-5
specifier, this needs to be confirmed in further studies
(Vieta and Valentí 2013).
Conclusions
The results of this study indicate that the M.I.N.I. module
administered as a self-questionnaire is a robust assessment
tool for assessing depressive symptoms in bipolar patients
with hypomania or mania, according to the DSM-5
‘With Mixed Features’ specifier. Due to its simplicity,
the M.I.N.I. module can easily be incorporated into the
routine psychiatric evaluation of patients with manic
episodes. It is also a valuable standardised tool for clin-
ical and epidemiological research in bipolar disorder.
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